Real-World Efficacy Outcomes of FLT3-ITD<sup>mut</sup> Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.

Gueta, Itai; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Loebstein, Ronen; Canaani, Jonathan

Real-World Efficacy Outcomes of FLT3-ITD^mut Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.

Gueta, Itai; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Loebstein, Ronen; Canaani, Jonathan.

Afiliación

Gueta I; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Marcu-Malina V; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Avigdor A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Shimoni A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Loebstein R; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Canaani J; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel. Electronic address: Jonathan.canaani@sheba.health.gov.il.

Clin Lymphoma Myeloma Leuk ; 23(2): 154-157, 2023 02.

Article en En | MEDLINE | ID: mdl-36564312

Asunto(s)

Leucemia Mieloide Aguda; Humanos; Estaurosporina/farmacología; Estaurosporina/uso terapéutico; Leucemia Mieloide Aguda/tratamiento farmacológico; Tirosina Quinasa 3 Similar a fms/genética; Mutación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google